McKesson EBITDA 2010-2025 | MCK

McKesson EBITDA for the quarter ending June 30, 2025 was $1.193B, a 0.42% decline year-over-year.

  • McKesson 2025 EBITDA was 5.058B, a 11.31% increase from 2024.
  • McKesson 2024 EBITDA was 4.544B, a 8.92% decline from 2023.
  • McKesson 2023 EBITDA was 4.989B, a 78.31% increase from 2022.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

McKesson EBITDA 2010-2025 | MCK

  • McKesson 2025 EBITDA was 5.058B, a 11.31% increase from 2024.
  • McKesson 2024 EBITDA was 4.544B, a 8.92% decline from 2023.
  • McKesson 2023 EBITDA was 4.989B, a 78.31% increase from 2022.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Becton Dickinson (BDX)$54.8B
Cardinal Health (CAH)$35.7B
Straumann Holding AG (SAUHY)$18.8B
West Pharmaceutical Services (WST)$17.6B
Cooper (COO)$12.9B
Align Technology (ALGN)$10.2B
Henry Schein (HSIC)$8.4B
Merit Medical Systems (MMSI)$5.3B
DENTSPLY SIRONA (XRAY)$2.9B
Patterson (PDCO)$2.8B
CONMED (CNMD)$1.7B
STAAR Surgical (STAA)$1.4B
Lifevantage (LFVN)$165M
Pro-Dex (PDEX)$151M